PMID- 26141030 OWN - NLM STAT- MEDLINE DCOM- 20170127 LR - 20170127 IS - 0125-877X (Print) IS - 0125-877X (Linking) VI - 33 IP - 2 DP - 2015 Jun TI - Effects of Xingbi gel on leukotriene E4 and immunoglobulin E production and nasal eosinophilia in a guinea pig model for allergic rhinitis. PG - 99-106 LID - 10.12932/AP0473.33.1.201510.12932/AP0520.33.2.2015 [doi] AB - BACKGROUND: Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal airways.Many therapies do not have immediate effects,even which have side-effects.However,the effects of Xingbi gel for the treatment of AR was investigated. OBJECTIVE: We investigated the effects of Xingbi gel on serum levels of leukotriene E4 (LTE4) and immunoglobulin E (IgE), as well as eosinophil counts in the nasal mucosa using a guinea pig model of allergic rhinitis (AR). METHODS: In addition to a healthy control group without AR, guinea pigs with AR were randomly divided into untreated AR control group, low-dose Xingbi gel (0.2483 g/mL) group, high-dose Xingbi gel (0.4966 g/mL) group, and budesonide group. RESULTS: Compared to the healthy controls, untreated AR guinea pigs had significantly higher ethology scores, serum LTE4 and IgE levels, and nasal mucosa eosinophil counts (p <0.01). Treatments with low-dose Xingbi gel, high-dose Xingbi gel, and budesonide significantly reduced the ethology scores, serum LTE4 and IgE levels, and nasal mucosa eosinophil counts as compared to untreated AR model guinea pigs (p <0.01). CONCLUSION: Xingbi gel alleviates AR in part through inhibiting LTE4 and IgE production and reducing eosinophilia in the nasal mucosa. FAU - Ai, Si AU - Ai S AD - Fujian University of Traditional Chinese Medicine, Huatuo Road No. 1 Minhou County, Fuzhou 350122, China. FAU - Zheng, Jian AU - Zheng J FAU - Chu, Ke-Dan AU - Chu KD FAU - Zhang, Hong-Sheng AU - Zhang HS LA - eng PT - Comparative Study PT - Journal Article PL - Thailand TA - Asian Pac J Allergy Immunol JT - Asian Pacific journal of allergy and immunology JID - 8402034 RN - 0 (Anti-Allergic Agents) RN - 0 (Biomarkers) RN - 0 (Drugs, Chinese Herbal) RN - 0 (Gels) RN - 0 (xingbi) RN - 37341-29-0 (Immunoglobulin E) RN - 51333-22-3 (Budesonide) RN - 75715-89-8 (Leukotriene E4) SB - IM MH - Administration, Intranasal MH - Animals MH - Anti-Allergic Agents/administration & dosage/*pharmacology MH - Biomarkers/blood MH - Budesonide/pharmacology MH - Disease Models, Animal MH - Drugs, Chinese Herbal/administration & dosage/*pharmacology MH - Eosinophilia/blood/*drug therapy/immunology MH - Gels MH - Guinea Pigs MH - Immunoglobulin E/*blood/immunology MH - Leukotriene E4/*blood/immunology MH - Male MH - Nasal Mucosa/*drug effects/immunology/metabolism MH - Rhinitis, Allergic/blood/*drug therapy/immunology EDAT- 2015/07/05 06:00 MHDA- 2017/01/28 06:00 CRDT- 2015/07/05 06:00 PHST- 2014/05/16 00:00 [received] PHST- 2014/08/15 00:00 [accepted] PHST- 2015/07/05 06:00 [entrez] PHST- 2015/07/05 06:00 [pubmed] PHST- 2017/01/28 06:00 [medline] AID - 10.12932/AP0473.33.1.201510.12932/AP0520.33.2.2015 [doi] PST - ppublish SO - Asian Pac J Allergy Immunol. 2015 Jun;33(2):99-106. doi: 10.12932/AP0473.33.1.201510.12932/AP0520.33.2.2015.